Danaher Corporation (DHR) Shares Sold by Braun Stacey Associates Inc.

Braun Stacey Associates Inc. trimmed its stake in shares of Danaher Corporation (NYSE:DHR) by 19.8% in the third quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 125,348 shares of the company’s stock after selling 30,933 shares during the quarter. Braun Stacey Associates Inc.’s holdings in Danaher Corporation were worth $10,752,000 at the end of the most recent reporting period.

A number of other hedge funds also recently added to or reduced their stakes in the business. Vanguard Group Inc. boosted its position in Danaher Corporation by 1.3% during the second quarter. Vanguard Group Inc. now owns 41,488,407 shares of the company’s stock worth $3,501,206,000 after purchasing an additional 520,776 shares during the period. BlackRock Inc. boosted its position in Danaher Corporation by 3.2% during the second quarter. BlackRock Inc. now owns 39,201,798 shares of the company’s stock worth $3,308,239,000 after purchasing an additional 1,233,876 shares during the period. FMR LLC boosted its position in Danaher Corporation by 0.9% during the second quarter. FMR LLC now owns 19,624,350 shares of the company’s stock worth $1,656,100,000 after purchasing an additional 183,183 shares during the period. Geode Capital Management LLC boosted its position in Danaher Corporation by 6.0% during the first quarter. Geode Capital Management LLC now owns 5,815,659 shares of the company’s stock worth $496,687,000 after purchasing an additional 329,458 shares during the period. Finally, Flossbach Von Storch AG boosted its position in Danaher Corporation by 44.7% during the second quarter. Flossbach Von Storch AG now owns 5,782,019 shares of the company’s stock worth $487,945,000 after purchasing an additional 1,785,810 shares during the period. 75.38% of the stock is owned by hedge funds and other institutional investors.

ILLEGAL ACTIVITY WARNING: “Danaher Corporation (DHR) Shares Sold by Braun Stacey Associates Inc.” was first published by The Ledger Gazette and is owned by of The Ledger Gazette. If you are viewing this piece on another publication, it was stolen and reposted in violation of U.S. and international copyright and trademark laws. The original version of this piece can be viewed at https://ledgergazette.com/2017/11/13/danaher-corporation-dhr-shares-sold-by-braun-stacey-associates-inc.html.

Shares of Danaher Corporation (NYSE:DHR) opened at C$92.24 on Monday. Danaher Corporation has a twelve month low of C$76.27 and a twelve month high of C$93.36. The company has a market capitalization of $64,162.62, a P/E ratio of 23.71, a P/E/G ratio of 2.19 and a beta of 1.02. The company has a quick ratio of 1.00, a current ratio of 1.43 and a debt-to-equity ratio of 0.42.

Danaher Corporation (NYSE:DHR) last issued its quarterly earnings results on Thursday, October 19th. The company reported C$1.00 earnings per share (EPS) for the quarter, beating the Thomson Reuters’ consensus estimate of C$0.95 by C$0.05. Danaher Corporation had a return on equity of 11.29% and a net margin of 13.36%. The firm had revenue of C$4.53 billion for the quarter, compared to analyst estimates of C$4.47 billion. During the same period in the previous year, the firm earned $0.87 earnings per share. The company’s revenue was up 9.6% compared to the same quarter last year. equities analysts predict that Danaher Corporation will post 3.99 EPS for the current fiscal year.

The firm also recently declared a quarterly dividend, which was paid on Friday, October 27th. Shareholders of record on Friday, September 29th were paid a $0.14 dividend. This represents a $0.56 annualized dividend and a yield of 0.61%. The ex-dividend date was Thursday, September 28th. Danaher Corporation’s dividend payout ratio (DPR) is presently 16.52%.

DHR has been the subject of a number of research analyst reports. Jefferies Group LLC reaffirmed a “buy” rating and set a $95.00 price objective on shares of Danaher Corporation in a research report on Friday, August 4th. Zacks Investment Research raised Danaher Corporation from a “hold” rating to a “buy” rating and set a $97.00 target price for the company in a report on Thursday, October 5th. Cowen and Company reissued a “buy” rating and set a $90.00 target price on shares of Danaher Corporation in a report on Wednesday, October 4th. Citigroup Inc. set a $96.00 target price on Danaher Corporation and gave the stock a “buy” rating in a report on Friday, July 21st. Finally, BidaskClub raised Danaher Corporation from a “sell” rating to a “hold” rating in a report on Wednesday, July 19th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating, thirteen have issued a buy rating and one has assigned a strong buy rating to the company. The company currently has a consensus rating of “Buy” and a consensus target price of C$93.31.

In other news, insider William King sold 43,688 shares of the company’s stock in a transaction that occurred on Thursday, August 31st. The stock was sold at an average price of C$82.86, for a total transaction of C$3,619,987.68. Following the transaction, the insider now directly owns 45,748 shares of the company’s stock, valued at C$3,790,679.28. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, CAO Robert S. Lutz sold 11,189 shares of the company’s stock in a transaction that occurred on Monday, October 23rd. The stock was sold at an average price of C$91.66, for a total value of C$1,025,583.74. Following the transaction, the chief accounting officer now directly owns 18,314 shares in the company, valued at C$1,678,661.24. The disclosure for this sale can be found here. Over the last three months, insiders sold 279,628 shares of company stock worth $25,304,394. Insiders own 12.20% of the company’s stock.

About Danaher Corporation

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Institutional Ownership by Quarter for Danaher Corporation (NYSE:DHR)

Receive News & Ratings for Danaher Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corporation and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply